Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years. Issue 3 (23rd February 2019) - Provencio, Mariano; Franco, Fernando; Gómez-Codina, José; Quero Blanco, Cristina; Llanos, Marta; Garcia-Arroyo, Francisco; de la Cruz, Luis; Gumá, Josep; Delgado, Juan Ramón; Álvarez, Ruth; Chacón, José Ignacio; Royuela, Ana; et al.